Companies Reporting Before The Bell
• Tencent Music Enter Gr TME is projected to report quarterly earnings at $0.14 per share on revenue of $931.97 million.
• HUYA HUYA is likely to report quarterly loss at $0.12 per share on revenue of $210.04 million.
• Caleres CAL is expected to report quarterly earnings at $0.85 per share on revenue of $694.33 million.
• XPeng XPEV is likely to report quarterly loss at $0.46 per share on revenue of $1.86 billion.
• Core & Main CNM is likely to report quarterly earnings at $0.35 per share on revenue of $1.43 billion.
• Citi Trends CTRN is likely to report quarterly earnings at $0.79 per share on revenue of $216.32 million.
• ZKH Group ZKH is projected to report earnings for its fourth quarter.
Companies Reporting After The Bell
• Mitek Systems MITK is likely to report earnings for its fourth quarter.
• Orla Mining ORLA is estimated to report earnings for its fourth quarter.
• Design Therapeutics DSGN is estimated to report earnings for its fourth quarter.
• HealthEquity HQY is projected to report quarterly earnings at $0.56 per share on revenue of $258.13 million.
• TeraWulf WULF is projected to report quarterly loss at $0.02 per share on revenue of $24.16 million.
• Taysha Gene Therapies TSHA is likely to report quarterly loss at $0.11 per share on revenue of $2.65 million.
• Cyclacel Pharmaceuticals CYCC is expected to report earnings for its fourth quarter.
• Corvus Pharma CRVS is estimated to report earnings for its fourth quarter.
• Bridger Aerospace Gr BAER is projected to report earnings for its fourth quarter.
• Relmada Therapeutics RLMD is likely to report earnings for its fourth quarter.
• ZTO Express (Cayman) ZTO is expected to report quarterly earnings at $0.37 per share on revenue of $1.52 billion.
• Precigen PGEN is expected to report quarterly loss at $0.08 per share on revenue of $1.70 million.
• Harrow HROW is projected to report quarterly loss at $0.04 per share on revenue of $37.86 million.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.